Monday - Friday, 6:00 - 9:00 AM ET AbbVie bets $10.9 billion on Apogee in next-generation immunology growth push United States Monday - Friday 6a ET Europe Monday - Friday 13:00 CET Asia Monday - ...

Alan Greenspan presided over the Federal Reserve for 19 years under four presidents and mastered the art of obfuscation known as Fedspeak.

U.S. equity futures were lower on Sunday as Wall Street awaited the release of inflation data that is closely watched by the Federal Reserve.

AbbVie said on Monday it would buy biotech Apogee ⁠Therapeutics for $10.9 billion, in its largest buyout in more than ​five years ​as it ​looks to strengthen its next-gen immunology pipeline.

Leo Pareja, Chief Executive Officer of eXp Realty, says housing is highly localized, first time buyers have rare ...

Apogee Therapeutics — The biotechnology company soared 50% after AbbVie confirmed it will acquire the company. The $10.9 billion transaction will see AbbVie acquire all outstanding shares of Apogee ...

Ami Daniel, Co Founder and Chief Executive Officer of Windward, says shipping confidence in the Strait of Hormuz remains weak ...

Ben Emons, Founder of FedWatch Advisors, says fiscal risks are driving higher bond premiums globally, lower oil prices may ...

Prime Minister Keir Starmer announces his resignation as UK Prime Minister and Leader of the Labour Party, outside No.10 ...

ASML is likely to outperform as its semiconductor fabrication business sees an influx of orders due to a combination of catalysts, including calls for more powerful memory solutions, according to Bank ...

Vice President JD Vance delivers remarks after Iran negotiations in Switzerland. Got a confidential news tip? We want to hear ...

Patrick Rishe, Washington University in St. Louis director of sports business program and Sportsimpacts founder and president ...